FIELD: pharmaceutics.
SUBSTANCE: present invention relates to magnesium-bis(-3-pyridinecarbonoate), which has antihypoxic, antiamnestic and neuroprotective activity. The present invention also relates to the use of the compound for the prevention and treatment of hypoxia of various origins and ischemic stroke.
EFFECT: technical result of the present invention is the creation of a new drug that has antihypoxic, antiamnestic and neuroprotective activity.
2 cl, 4 ex, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
| DRUG POSSESSING ACTOPROTECTIVE, ANTIHYPOXIC, NEUROPROTECTIVE, ANTIAMNESTIC AND THERMOPROTECTIVE ACTIVITY | 2011 |
|
RU2460529C1 |
| NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
| ERGOGENIC PHARMACEUTICAL COMPOSITION EXHIBITING ANTIHPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY | 2010 |
|
RU2435605C1 |
| PHARMACEUTIC COMPOSITION, POSSESSING ANTIHYPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY AND INCREASING PHYSICAL PERFORMANCE CAPACITY | 2010 |
|
RU2425670C1 |
| COMPOSITION EXHIBITING NEUROPROTECTIVE, ANTIAMNESTIC, ANTIHYPOXIC AND ANTIISCHEMIC ACTIVITY | 2006 |
|
RU2440132C2 |
| AGENT WITH ANTIHYPOXIC ACTIVITY | 2022 |
|
RU2797210C1 |
| AGENT FOR PREVENTION AND TREATMENT OF ACUTE AND CHRONIC CEREBROVASCULAR DISEASE, USE AND METHOD OF TREATING | 2011 |
|
RU2468813C1 |
| AGENT WITH PANCREAS AND HEPATOPROTECTIVE ACTIVITY FOR PARENTERAL ADMINISTRATION | 2017 |
|
RU2662324C1 |
| PHARMACEUTICAL COMPOSITION, POSSESSING ANTIHYPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY, INCREASING PHYSICAL WORKABILITY | 2013 |
|
RU2564008C2 |
